A new species of Streptomyces rubrum and its applications
By isolating and identifying a new species of Streptomyces rubrum SCA2-17 and its volatile gases, the problem of insufficient existing biological control microbial resources has been solved, enabling effective control of various plant diseases and improving the quality and control effect of agricultural products.
Patent Information
- Application Number
- CN202610310811.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-13
- Publication Date
- 2026-11-10
AI Technical Summary
The existing biological control bacteria resource bank is limited, and its control effect is unstable in different regional environments. It is necessary to discover new biological control bacteria to expand the resource bank and improve the control effect on plant diseases and the quality of agricultural products.
A new species of Streptomyces SCA2-17 was isolated and identified. This strain can produce volatile gases with broad-spectrum antibacterial activity, including 2-propyl-1-pentanol, 2-methylisoborneol, tetradecane and 2-methyl-2-borneol, which are used in formulations to control a variety of plant diseases.
Streptomyces rubrum SCA2-17 exhibits significant antifungal activity against a variety of plant pathogenic fungi, especially against Fusarium wilt pathogen race 4 of banana and other plant diseases, with inhibition rates ranging from 60.4% to 51.6%, demonstrating good broad-spectrum biocontrol potential and improving the effectiveness of plant disease control.
Smart Images

Figure CN123063301A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of microbiology, and more particularly to a new species of Streptomyces rubrum and its applications. Background Technology
[0002] Biological control refers to the control measures that inhibit pathogen infection through specific antagonistic microorganisms. Biological control can reduce disease incidence and the amount of chemical pesticides used through microbial products, making it environmentally friendly and beneficial to agricultural products. Some microorganisms can even improve the yield and quality of agricultural products. However, the existing pool of usable biological control bacteria is limited, and the control efficacy of biocontrol bacteria is unstable in different geographical environments, often undergoing mutations and degeneration during practical application. Therefore, it is necessary to continuously discover new biological control bacteria to expand the resource pool.
[0003] Actinomycetes are a class of terrestrial prokaryotes that primarily grow as mycelia and reproduce by spores. In the field of biological control of plant diseases, actinomycetes are an ideal biological control method with broad application prospects. Therefore, developing new actinomycete strains is of great significance for the control of plant diseases and pests and the improvement of agricultural product quality. Soil is the main environment for obtaining actinomycete resources, and arid and hot valleys are a natural treasure trove of microorganisms. Therefore, using rhizosphere soil from arid and hot valleys as isolation material to isolate novel active microbial strains with broad-spectrum antibacterial effects is of great significance for controlling plant diseases and improving crop quality.
[0004] Actinomycetes are a group of terrestrial prokaryotes that primarily grow in filamentous form and reproduce by spores. They are important producers of bioactive secondary metabolites with antibacterial and / or antitumor and / or antiviral activities. More than 50% of known antibiotics derived from microorganisms are produced by actinomycetes, and approximately 75% of these are produced by *Streptomyces*. In the field of biological control of plant diseases, actinomycetes have broad application prospects as an ideal biological control method. However, it is predicted that more than 90% of *Streptomyces* bioactive metabolites remain to be discovered. As one of the most significant producers of bioactive secondary metabolites in terms of quantity, structural diversity, and diversity, *Streptomyces* remains the most promising candidate species for producing new types of secondary metabolites (Berdy, 2005). Therefore, the isolation and identification of *Streptomyces* has always been a focus of attention. Summary of the Invention
[0005] The purpose of this invention is to overcome the shortcomings of the prior art and provide a new species of Streptomyces rubrum and its applications.
[0006] The first aspect of the present invention is to provide a bright red Streptomyces SCA2-17 ( Streptomycessp. SCA2-17), classified as Streptomyces sp. is registered and preserved at the Guangdong Provincial Center for Microbial Culture Collection, with accession number GDMCC No: 63010.
[0007] A second aspect of the invention is to provide a fermentation broth of *Streptomyces rubrum* SCA2-17 as described in the first aspect of the invention.
[0008] A third aspect of the invention is to provide volatile gases produced by fermentation of *Streptomyces rubrum* SCA2-17 as described in the first aspect of the invention.
[0009] Preferably, the volatile gas is the volatile organic compound produced after activated Streptomyces redissus SCA2-17 is inoculated onto YE plates and cultured at 28°C for 5-7 days to allow it to grow fully.
[0010] The main components of the volatile gas include 2-propyl-1-pentanol, 2-methylisoborneol, tetradecane, and 2-methyl-2-borneolene.
[0011] In addition, the volatile gas also contains styrene, undecane, pentadecane and trans-1,10-dimethyl-trans-9-decahydronaphthol.
[0012] A fourth aspect of the present invention is to provide a formulation containing the *Streptomyces rubrum* SCA2-17 described in the first aspect of the present invention, or the fermentation broth described in the second aspect of the present invention, or the volatile gas described in the third aspect of the present invention.
[0013] The fifth aspect of the invention is to provide the use of *Streptomyces rubrum* SCA2-17 as described in the first aspect of the invention, or the fermentation broth as described in the second aspect of the invention, or the volatile gas as described in the third aspect of the invention, or the formulation as described in the fourth aspect of the invention, in the preparation of formulations antagonizing *Fusarium wiltii* race 4, and / or *Fusarium oxysporum*, and / or *Anthracnose*, and / or *Agropyron cristatum*, and / or *Fusarium wiltii*, and / or *Agropyron cristatum*, and / or *Anthracnose*, and / or *Fusarium oxysporum*, and / or *Anthracnose*, and / or *Fusarium oxysporum*, and / or *Anthracnose*, and / or *Fusarium oxysporum*, and / or *Fusarium oxysporum*, and / or *Fusarium oxysporum*, and / or *Fusarium oxysporum*, and / or *Anthracnose ...
[0014] The sixth aspect of the present invention is to provide the use of *Streptomyces rubrum* SCA2-17 as described in the first aspect of the present invention, or the fermentation broth as described in the second aspect of the present invention, or the volatile gas as described in the third aspect of the present invention, or the formulation as described in the fourth aspect of the present invention, in the preparation of formulations for controlling diseases caused by *Fusarium wiltii* race 4 of banana, and / or *Fusarium oxysporum* var. *banana*, and / or *Anthracnose* var. *chinensis*, and / or *Fusarium wiltii* var. *mango*, and / or *Fusarium wiltii* var. *tomato*, and / or *Anthracnose* var. *mango*, and / or *Anthracnose* var. *banana*, and / or *Fusarium graminearum* var. *wheat*, and / or *Anthracnose* var. *papaya*.
[0015] The *Streptomyces rubrum* SCA2-17 strain of the present invention and the volatile gases produced by its fermentation have broad-spectrum antibacterial activity. SCA2-17 exhibits antibacterial activity against *Fusarium oxysporum* race 4 (Fu... sarium oxysporum f. sp.C ubense The inhibition rate of *Streptomyces race 4* (Foc TR4) was 60.4%. The volatile organic compounds produced by *Streptomyces* SCA2-17 showed significant inhibitory activity against eight plant pathogenic fungi, including *Streptomyces longifolia*, *Streptomyces causalina*, *Fusarium wilt*, *Anthracnose*, *Fusarium wilt*, *Anthracnose*, *Fructus leaf blight*, *Anthracnose*, *Fusarium graminearum*, and *Anthracnose*. The inhibitory effects against *Streptomyces longifolia*, *Anthracnose*, and *Anthracnose* were particularly prominent, with inhibition rates ranging from 46.8% to 51.6%, demonstrating good broad-spectrum biocontrol potential. Attached Figure Description
[0016] Figure 1 The culture characteristics of strain SCA2-17 on eight different culture media are shown.
[0017] Figure 2 Morphological characteristics of strain SCA2-17 (scanning electron microscopy).
[0018] Figure 3 Physiological and biochemical characteristics of strain SCA2-17. Left image: The cell wall amino acids of sample SCA2-17 mainly contain LL-DAP (LL-diaminopimelic acid); Tween 60: The halo indicates that strain SCA2-17 can degrade Tween 60; Siderophores: The yellow ring around the colony indicates that strain SCA2-17 can produce siderophores; Antibiotic sensitivity: The blank ring around the antibiotic disc indicates that strain SCA2-17 is sensitive to the antibiotic, while the absence of a blank ring indicates resistance.
[0019] Figure 4Phylogenetic tree of strain SCA2-17 constructed based on the 16S rRNA gene sequence (neighbor-joining method). The numbers on the branch nodes represent the percentage of the self-expansion value based on 1000 replicates (>50%). The scale bar corresponds to 0.002 substitutions at each nucleotide site.
[0020] Figure 5 This is a phylogenetic tree of strain SCA2-17 constructed based on the genome-wide average nucleotide distance (GBDP method). The tree was inferred using the Balanced Minimal Evolution (FASTME) method via the TYGS server, with branch support based on 100 pseudo-bootstrapping replicates. Node numbers represent the bootstrap percentage (>60%).
[0021] Figure 6 The inhibitory effect of SCA2-17 strain on FOC TR4 (left: FOC TR4 control, right 2: confrontation between SCA2-17 strain and FOC TR4).
[0022] Figure 7 The study investigated the inhibitory effects of volatile organic compounds from strain SCA2-17 on eight plant pathogenic fungi.
[0023] Figure 8 Here is the GC-MS mass spectrum (A: strain SCA2-17; B: YE medium).
[0024] The fungus *Streptomyces rubrum* SCA2-17 was named Streptomyces sp. SCA2-17 is deposited at the Guangdong Provincial Center for Microbial Culture Collection, with accession number GDMCC No: 63010, on November 28, 2022. The deposit address is the Institute of Microbiology, Guangdong Academy of Sciences, 5th Floor, Building 59, No. 100 Xianlie Middle Road, Guangzhou. Detailed Implementation
[0025] The present invention will be further described below with reference to the accompanying drawings and specific embodiments to better understand the invention. Where specific techniques or conditions are not specified in the embodiments, they are performed according to the techniques or conditions described in the literature in the art or according to the product instructions. Reagents or instruments whose manufacturers are not specified are all conventional products that can be obtained commercially.
[0026] Example 1
[0027] 1. Isolation of strain SCA2-17 In January 2014, soil samples from the rhizosphere of cacti were collected in the dry-hot valley area of Huili County, Sichuan Province. After drying the soil samples at room temperature and passing them through a 0.425 mm mesh sieve, 1 gram of soil sample was weighed and mixed in 9 ml of sterile water, and then heated in a 55°C water bath for 20 minutes. After serial dilution, 100 µL of the solution was spread onto starch-casein agar plates (SCA: 10 g of soluble starch, 0.3 g of casein, 2.0 g of KNO3, 2.0 g of NaCl, 2.0 g of K2HPO4, 0.05 g of MgSO4·7H2O, 0.02 g of CaCO3, 0.01 g of FeSO4·H2O, and 18 g of agar in 1 L of sterile water, pH 7.0–7.4). K2Cr2O7 (50 mg / L) and nystatin (50 mg / L) were added to the medium to inhibit fungal and bacterial growth. The plates were incubated at 28°C for 7 days. Strain SCA2-17 was isolated from these plates and purified on YE agar medium (YE: 10 g of yeast extract, 10 g of malt extract, and 4 g of glucose in 1 L of distilled water, pH 7.3). The purified strain SCA2-17 was streaked onto YE agar slants and stored at 4°C, while also being preserved long-term with 20% (v / v) glycerol at -80°C.
[0028] 2. Phenotypic characteristics analysis of strain SCA2-17 Strain SCA2-17 was inoculated on YE medium and cultured at 28°C for 14 days. Its microstructure was observed using a scanning electron microscope (ZEISS, Germany), as described by Kumar et al. (2014). Simultaneously, strain SCA2-17 was inoculated on six standard ISP media (Shirling and Gottlieb, 1966) and cultured at 28°C for 14 days to observe its culture characteristics. ISP media included yeast extract-malt extract agar (ISP 2 or YE), oat extract agar (ISP 3), inorganic salt-starch agar (ISP 4), glycerol-asparagine agar (ISP 5), peptone-yeast agar (ISP 6), and tyrosine agar (ISP 7). Melanin formation was observed on ISP 6 and ISP 7. The colors of substrate hyphae, aerial hyphae, and soluble pigments were compared with the ISCC-NBS color chart (Kelly, 1964). SCA2-17 strain was inoculated onto YE plates containing NaCl (0-9%, 1% interval, w / v) and cultured at 28°C for 14 days to assess its salt tolerance. SCA4-21 strain was inoculated into NB broth (1.0 g yeast extract, 0.8 g beef extract, 2.0 g casein, 10.0 g glycerol) at pH 4-10 (interval), and cultured at 28°C for 7 days to evaluate the effect of pH on its growth. Other physiological and biochemical characteristics were determined according to the methods of Shirling and Gottlieb (1966) and Williams et al. (1983).
[0029] The results showed that strain SCA2-17 was an aerobic, Gram-positive bacterium. It grew well on ISP2, ISP4, and ISP6 media, and moderately on other media. Aerial mycelia were pink on ISP2, ISP3, ISP7, Gao's No. 1 medium, and PDA medium; red on ISP4 and ISP5 medium; and beige on ISP6 medium. Except for the production of a blackish-gray soluble pigment on ISP2 and PDA, no vitamins were produced on other media. Colony morphology was round; on ISP4, ISP5, and Gao's No. 1 medium, the colony was centrally convex, soft in texture, and had a velvety surface; on ISP2, ISP3, ISP6, ISP7, and PDA medium, the colony was dense, with ISP2 having a smooth surface, ISP3 a porous surface, ISP6 a wrinkled surface, and ISP7 and PDA surfaces having depressions. Figure 1 Fourteen days after observing the culture characteristics of strain SCA2-17, the mycelial growth, spore morphology, and spore chain morphology of SCA2-17 on ISP2 agar plates were observed using scanning electron microscopy. The results showed that the substrate and aerial mycelium of strain SCA2-17 were cylindrical and unbranched, and no spores or spore chains were observed. Figure 2 ).
[0030] The results also showed that strain SCA2-17 grew at a pH of 5.0–8.0% (optimal pH 7.0%) and a NaCl concentration of 1–3% (w / v), with an optimum NaCl concentration of 3%. Strain SCA4-4 could degrade esterases Tween40 and Tween60 and gelatin, producing melanin and siderophores, but could not degrade Tween80 and starch, nor reduce nitrates. It could not produce auxin, nor solubilize phosphorus and potassium, nor fix nitrogen. It can utilize carbon sources such as D-mannose, D-trehalose, L-arabinose, sorbitol, D-fructose, D-ribose, mannitol, xylan, and inositol, but has difficulty utilizing α-lactose, raffinose, and mannitol. Regarding nitrogen source utilization, strain SCA2-17 is relatively resistant to L-asparagine, L-valine, L-histidine, D-cellobiose, tryptophan-glycine, and L-hydroxyproline, but has difficulty utilizing L-phenylalanine, arginine, L-tyrosine, cysteine, and anhydrous inositol, and cannot utilize L-glutamic acid and L-tryptophan. Strain SCA2-17 is resistant to penicillin, ampicillin, ceftriaxone, lincomycin, and trimethoprim-sulfamethoxazole, but sensitive to gentamicin, tetracycline, erythromycin, ciprofloxacin, and chloramphenicol. Figure 3 ).
[0031] 3. Chemical classification characteristics of strain SCA2-17 Chemical classification characteristics analysis: Respiratory quinones were determined according to the method of Minnikin et al. (Minnikin, DE, O'Donnell, AG, Goodfellow, M., Alderson, G., Athalye, M., Schaal, A., & Parlett, JH (1984). An integrated procedure for the extraction of bacterial isoprenoidquinones and polar lipids. Journal of Microbiological Methods, 2(5), 233-241.), and fatty acids were determined according to Sasser's method (Sasser, M. (1990). Identification of Bacteria by Gas Chromatography of Cellular Fatty Acids, MIDI Technical Note 101. Newark, DE: MIDI Inc.); the determination of cell wall amino acid composition was based on Hasegawa (Hasegawa, T., Takizawa, M. & Tanida, S. (1983). A rapid analysis for chemical grouping of aerobic actinomycetes. J Gen Appl Microbiol Methods such as 29, 319–322.
[0032] The major respiratory quinones of strain SCA4-4 consist of MK8(H6) (7.04%), MK9(H6) (35.17%), and MK9(H8) (57.79%), with major fatty acids exceeding 10% including anteiso-C15:0 (34.78%) and C16:0 (19.89%). The main amino acid in the cell wall is LL-diaminopimelic acid. These taxonomic characteristics are consistent with those of Streptomyces.
[0033] Phylogenetic and genomic analysis of four strains of SCA2-17 Genomic DNA was extracted according to the method of Ahmad et al. (2017). The 16S rRNA gene fragment of strain SCA2-17 was amplified using primer pairs 27F (5'-AGAGTTTGATCCTGGCTCAG-3') and 1492R (5'-GGTTACCTTGTTACGACTT-3') (Wang et al., 2015). The amplified products were sent to Sangon Biotech (Shanghai) Co., Ltd. for 16S rRNA sequencing. Whole genome sequencing and assembly were performed by the same company. The 16S rRNA gene was compared for similarity with corresponding sequences in the EzTaxon server (Yoon et al., 2017) and the NCBI database. Phylogenetic trees were constructed using the MEGA 7.0 program and three methods: Neighbour-Joining Algorithms, Maximum-parsimony Algorithms, and Maximum Likelihood Algorithms. The evolutionary distance and confidence scores of the phylogenetic trees were calculated using Kimura's (1980) two-parameter model and spin-off analysis with 1000 replicates (Felsenstein, 1985). Genome phylogenetic trees were constructed using the Type (Strain) Genome Server (TyGS) with default parameters. Digital DNA hybridization values (dDDH values) were calculated (Meier-Kolthoff et al., 2022), and the average nucleotide identity (ANI) between genomes was calculated online using OrthoANI (Yoon et al., 2017) to identify the phylogenetic position of strain SCA2-17.
[0034] EzBioCloud alignment of the complete 16S rRNA gene sequence (1429 bp) of strain SCA2-17 indicates that this strain belongs to the genus Streptomyces. It is consistent with strain... Streptomyces griseocarneus JCM 4580 showed the highest sequence similarity (98.6%), with a similarity of 98.18% to Streptomyces alboverticillatus NBRC 13861. However, a phylogenetic tree based on 16S rRNA gene sequences using the neighbor-joining algorithm showed that strain SCA2-17 formed a separate branch with Streptomyces alboverticillatus NBRC 13861, with a developmental value of 75%. Figure 4 Phylogenetic trees constructed using maximum likelihood and maximum parsimony algorithms showed that this strain formed the same branches as *Streptomyces alboverticillatus* NBRC 13861, with self-spreading rates of 57% and 58%, respectively (results omitted). Due to the low resolution of the 16S rRNA gene for closely related species, to further investigate the phylogenetic position of strain SCA2-17, a phylogenetic tree was constructed between the SCA2-17 genome and closely related species using the Type (Strain) Genome Server (TyGS). The results showed that strain SCA2-17 and... Streptomyces baldaccii ( roseoverticillatus NRRL B-3500 belongs to the same subcluster, with a pseudo-bootstrapping value of 100%. Figure 5 ).
[0035] To determine the taxonomic position of strain SCA2-17, we performed a genomic comparison with five closely related species on the phylogenetic tree (Table 1). The results showed that strain SCA2-17 is related to... Streptomyces baldaccii ( roseoverticillatus NRRL B-3500 is the most closely related strain, and the genomic similarity indicators between the two (dDDH value 48.3%, ANI value 92.47%) are both below the generally accepted species-defining thresholds (dDDH < 70%, ANI < 95–96%). Therefore, based on the above genotype data, strain SCA2-17 represents a new species of the genus *Streptomyces*, and is named *Streptomyces rubrum*. Streptomyces sp. SCA2-17) was deposited at the Guangdong Provincial Center for Microbial Culture Collection (GDMCC No: 63010) on November 28, 2022. The deposit address is the Institute of Microbiology, Guangdong Academy of Sciences, 5th Floor, Building 59, No. 100 Xianlie Middle Road, Guangzhou.
[0036] Table 1. dDDH and ANI values of strain SCA2-17 and closely related species Strains dDDH (%) ANI(%) ( ) NRRL B-3500 48.3 92.47 AA8 36.3 88.6 JCM 4586 36.4 88.69 MBT76 36.6 88.69 NRRL B-24281 26.6 82.81
[0037] 5. Determination of the activity of strain SCA2-17 against FOC TR4, the causal agent of banana wilt. The four-spot inoculation method was used to determine the effect of strain SCA2-17 on physiological race 4 of Fusarium wilt of banana (… Fusarium oxysporum f. sp. cubenseThe antagonistic activity of tropical race 4 (FOC TR4, ATCC 76255) was investigated. The antagonistic bacteria (SCA2-17) and the pathogen FOC TR4 were pre-cultured on PDA plates at 28°C for 7 days. Mycelial blocks with a diameter of 0.5 cm were cut using a sterile punch as inoculum. On a fresh PDA plate, four antagonistic mycelial blocks were inoculated symmetrically at four points along the edge of the plate (approximately 2.5 cm from the edge), and one pathogen FOC TR4 mycelial block was inoculated in the center of the plate. A plate inoculated only in the center served as a negative control. All plates were incubated in the dark at 28°C until the pathogen colonies on the negative control plate completely covered the plate. The colony diameter (A) of FOC TR4 in the control plate and the colony diameter (B) of FOC TR4 in the treated plate were measured using the cross-sectional method, and the inhibition rate was calculated using the following formula: Inhibition rate (%) = (A - B) / A × 100%. Results are shown below. Figure 6 As shown, the calculated inhibition rate of strain SCA2-17 against FOC TR4 was approximately 60.4%. This result confirms that strain SCA2-17 can effectively inhibit the mycelial growth of FOC TR4 and possesses significant in vitro antagonistic potential.
[0038] Determination of volatile gaseous antifungal activity of 6 strains SCA2-17 The antimicrobial spectrum of volatile organic compounds (VOCs) of strain SCA2-17 was determined using a modified double-plate inversion method. First, the activated antagonistic Streptomyces SCA2-17 was streaked onto YE plates and incubated at 28°C for 5-7 days until full growth was achieved. Simultaneously, eight target pathogenic fungi, *Streptomyces lucida*, were tested. Falvularia fallax (ATCC 34598), Anthracnose of Chinese cabbage Colletotrichum higginsianum (KACC 40807), Mango Leaf Blight Pathogen Pestalotiopsis mangiferae (ACCC 36820) Fusarium wilt of tomato Fusarium oxysporum f. sp. lycopersici (ATCC MYA-1199), Mango anthracnose fungus Colletotrichum gloeosporioides (ATCC 58222), Banana anthracnose fungus Colletotrichum musae (ATCC 96726) Wheat scab Fusarium graminearum (ATCC MYA-4620) and papaya anthracnose fungus Colletotrichum gloeosporioides(ATCC 20438) The pathogen was spotted onto the center of a PDA plate. Then, the YE plate, already covered with SCA2-17, was immediately placed bottom-to-bottom and mouth-to-mouth with the freshly inoculated PDA plate, sealed with Parafilm, and co-cultured. The pathogen PDA plate, inverted against the blank YE plate, served as a negative control. All treatments were incubated at 28°C in the dark for 8 days. When the pathogen colonies in the negative control plate reached near the edge of the culture dish, the plates were removed, and the colony diameters of the pathogens in each treatment group and the control group were measured. The inhibition rate of volatile organic compounds of strain SCA2-17 was calculated using the formula: "Inhibition rate (%) = [(Control colony diameter - Treatment colony diameter) / Control colony diameter] × 100%". Each treatment was replicated three times.
[0039] The results showed that co-culturing with SCA2-17 significantly inhibited the growth of all pathogens and reduced the colony diameter. Figure 7 (See Table 2). Based on the inhibition rate formula, the inhibition rates of SCA2-17 against the above pathogens were, in descending order: 51.6%, 46.8%, 21.2%, 47.9%, 18.3%, 41.2%, 30.2%, and 33.6%. This indicates that the gaseous metabolites produced by SCA2-17 have a significant inhibitory effect on the mycelial growth of all tested pathogens.
[0040] Table 2. Antifungal effects of volatile organic compounds from strain SCA2-17 on eight plant pathogenic fungi. Pathogens Average diameter of control colonies (cm) Average diameter of treated colonies (cm) Antibacterial rate (%) Banana long spot disease 8.00 3.87 51.6 Anthracnose of Chinese cabbage 5.70 3.03 46.8 Fusarium wilt of tomatoes 8.33 6.57 21.2 Mango anthracnose fungus 7.87 4.10 47.9 Mango leaf blight fungus 5.67 4.63 18.3 Banana anthrax 8.50 5.00 41.2 wheat scab 5.73 4.00 30.2 Papaya anthracnose fungus 5.87 3.90 33.6
[0041] 7. Determination of volatile gases from strain SCA2-17 by GC-MS Volatile organic compounds (VOCs) of strain SCA2-17 were determined by gas chromatography-mass spectrometry (GC-MS): 100 µL of a 10... 6CFU mL⁻¹ of SCA2-17 bacterial suspension was inoculated into 50 mL Erlenmeyer flasks containing 15 mL of sterile YE medium, with an equal volume of sterile deionized water as a control. Three biological replicates were set for both the treatment and control groups. All Erlenmeyer flasks were sealed with sterile aluminum foil and sealing film and incubated at 28°C with shaking at 180 rpm for 7 days. Volatile compounds were headspace adsorbed for 40 min in a 50°C glycerol bath using a 50 / 30 µm DVB / CAR / PDMS solid-phase microextraction fiber tip, followed by thermal desorption for 3 min in a 250°C GC inlet. The GC was equipped with an ELITE-5MS capillary column (30 m × 0.25 mm × 0.25 μm), with the following temperature program: 40°C for 1 min, ramped up to 160°C in 3°C min⁻¹ increments, ramped up to 230°C in 15°C min⁻¹ increments and held for 2 min, then ramped up to 10°C... The temperature was increased to 250°C and held for 5 min, with high-purity helium as the carrier gas (1.0 mL min⁻¹). Mass spectrometry was performed using an electron impact source (70 eV), an ion source temperature of 250°C, and a scan range of m / z 35–300. The compounds were initially identified using the NIST11 mass spectrometry library. By comparing the VOC spectra of the treatment group and the control group, compounds unique to the treatment group or with significantly higher peak areas than the control group were screened out. The final confirmation was made by combining the retention index with reference standards.
[0042] GC-MS analysis results (see) Figure 8 (Table 3) After comparison with the control, strain SCA2-17 was found to contain eight major volatile organic compounds, including alkenes, alcohols, alkanes, and terpene derivatives. The main components included 2-propyl-1-pentanol (11.585%), 2-methylisoborneol (6.498%), tetradecane (6.438%), and 2-methyl-2-bornene (3.773%). In addition, styrene, undecane, pentadecane, and trans-1,10-dimethyl-trans-9-decalinol were also detected, but at relatively low levels. Some of these volatile substances may be involved in the ecological interactions or antibacterial functions of the strain.
[0043] Table 3. Major volatile substances of strain SCA2-17 determined by GC-MS. No Compound Name Relative retention time (min) Peak area percentage % CAS number Molecular formula 1 Styrene 7.461 0.392 100-42-5 <![CDATA[C8H8]]> 2 2-Methyl-2-bornene 13.485 3.773 72540-93-3 <![CDATA[C 11 H 18 ]]> 3 2-Propyl-1-pentanol 14.178 11.585 58175-57-8 <![CDATA[C8H 18 O]]> 4 Undecane 17.658 3.578 1120-21-4 <![CDATA[C 11 H 24 ]]> 5 2-Methylisoborneol 21.692 6.498 2371-42-8 <![CDATA[C 11 H 20 O]]> 6 Tetradecane 31.358 6.438 629-59-4 <![CDATA[C 14 H 30 ]]> 7 trans-1,10-Dimethyl-trans-9-decalinol 31.583 1.549 <![CDATA[C 12 H 22 O]]> 8 Pentadecane 35.423 2.604 629-62-9 <![CDATA[C 15 H 32 ]]> The specific embodiments of the present invention have been described in detail above, but they are only examples, and the present invention is not limited to the specific embodiments described above. For those skilled in the art, any equivalent modifications and substitutions to this utility model are also within the scope of the present invention. Therefore, all equivalent changes and modifications made without departing from the spirit and scope of the present invention should be covered within the scope of the present invention.
Claims
1. A bright red Streptomyces SCA2-17 ( Streptomyces sp. SCA2-17), characterized in that, Category naming Streptomyces sp. is registered and preserved at the Guangdong Provincial Center for Microbial Culture Collection, with accession number GDMCC No: 63010.
2. The fermentation broth of Streptomyces redissus SCA2-17 as described in claim 1.
3. The volatile gases produced by the fermentation of Streptomyces redissus SCA2-17 as described in claim 1.
4. The volatile gas as described in claim 3, characterized in that, The volatile gases are volatile organic compounds produced after activated Streptomyces redissus SCA2-17 is inoculated onto YE plates and cultured at 28°C for 5-7 days to allow it to grow fully.
5. The volatile gas as described in claim 4, characterized in that, The main components of the volatile gas include 2-propyl-1-pentanol, 2-methylisoborneol, tetradecane, and 2-methyl-2-borneolene.
6. The volatile gas as described in claim 5, characterized in that, It also contains styrene, undecane, pentadecane and trans-1,10-dimethyl-trans-9-decahydronaphthol.
7. A formulation, characterized in that, It contains the bright red Streptomyces SCA2-17 as described in claim 1, or the fermentation broth as described in claim 2, or the volatile gas as described in any one of claims 3-6.
8. The use of the *Streptomyces rubrum* SCA2-17 as described in claim 1, or the fermentation broth as described in claim 2, or the volatile gas as described in any one of claims 3-6, or the formulation as described in claim 7, in the preparation of formulations antagonizing *Fusarium wiltii* race 4, and / or *Fusarium oxysporum*, and / or *Anthracnose*, and / or *Amanita phalloides*, and / or *Fusarium wiltii*, and / or *Anthracnose*, and / or *Anthracnose*, and / or *Fusarium oxysporum ...
9. The use of the *Streptomyces rubrum* SCA2-17 as described in claim 1, or the fermentation broth as described in claim 2, or the volatile gas as described in any one of claims 3-6, or the formulation as described in claim 7, in the preparation of formulations for controlling diseases caused by *Fusarium wiltii* race 4, and / or *Fusarium oxysporum*, and / or *Anthracnose*, and / or *Fungiella vesicae*, and / or *Fusarium wiltii*, and / or *Anthracnose*, and / or *Anthracnose*, and / or *Fusarium oxysporum ...
